Astonea Labs IPO

Astonea Labs Ltd

₹1,28,000 /1000 sharesMinimum Investment

Astonea Labs IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹135.00₹137.45₹2.45 (1.81%)

Astonea Labs IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
27 May ‘25 - 29 May ‘25₹1,28,0001,000₹128 - ₹135
Issue SizeIPO Doc
37.67Cr
RHP PDF

Subscription rate

As of 29 May'25, 04:00 PM
Qualified Institutional Buyers1.75x
Non-Institutional Investor4.52x
Retail Individual Investor1.36x
Total1.43x

About Astonea Labs

Astonea Labs Limited is a pharmaceutical and cosmetic manufacturing company which produces and markets various products, including antibiotics, anti-cold drugs, antihistamines, and medicines for diabetes, cardiovascular issues, gynaecological conditions, pain relief, fungal infections, and nutritional needs. The company also manufactures cosmetic items such as skin, hair, and dental care products in various forms such as creams, gels, ointments, serums, oils, and lotions. Astonea Labs engages in contract manufacturing and also markets its own brands, Glow Up and Regero, with plans to introduce a new brand named Avicel. The company operates out of Haryana, India, where it has a manufacturing facility covering 7,500 square metres. It exports to international markets, including Iraq and Yemen. The company is ISO 9001:2015 certified for quality management systems, ISO 22000:2018 certified for food safety management systems, ISO 22716:2007 certified for good manufacturing practices and holds a halal certificate.;
Founded in
2017
Managing director
Mr. Ashish Gulati
Parent organisation
Astonea Labs Ltd

Strengths & Financials of Astonea Labs

Strengths
Risks
Astonea Labs claims to follow a scalable, customer-centric and order-driven business model that focuses on optimising existing resources.
The company claims to offer a broad range of pharmaceutical and cosmetic products, including treatments for diabetes, cardiovascular issues, gynaecological concerns, fungal infections, and more. This portfolio spans multiple dosage forms, such as tablets, capsules, creams, gels, and serums.
The company claims to have stringent systems in place to ensure timely delivery with minimal product rejection.
The company is ISO 9001:2015 certified for quality management systems, ISO 22000:2018 certified for food safety management systems, ISO 22716:2007 certified for good manufacturing practices and holds a halal certificate.
The company has seen a consistent increase in revenue from operations and profit after tax (PAT). Revenue from operations increased from Rs 30.06 crore in FY22 to Rs 67.05 crore in FY23 to Rs 80.19 crore in FY24, while PAT increased from Rs 0.25 crore in FY22 to Rs 0.66 crore in FY23 to Rs 3.81 crore in FY24.

Astonea Labs Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Astonea Labs IPO

Apply asPrice bandApply upto
Regular128 - 135₹2 Lakh
High Networth Individual128 - 135₹2 - 5 Lakh
For Astonea Labs IPO, eligible investors can apply as Regular.